Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CG Oncology, Inc. | 143,907 | reported | 15 Apr 2025 | tx 4+732,427 |
| IOVANCE BIOTHERAPEUTICS, INC. | 132,200 | reported | 09 Mar 2026 | tx 3+582,200 |
| Immunome Inc. | 58,000 | reported | 08 Jun 2023 | tx 4+269,609 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Mar 2026 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 132,200 | 0.00 USD | deriv |
| 06 Aug 2025 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 300,000 | 0.00 USD | deriv |
| 06 Aug 2025 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 150,000 | 0.00 USD | deriv |
| 15 Apr 2025 | GRANT_AWARD | CG Oncology, Inc. | 143,907 | 0.00 USD | deriv |
| 04 Oct 2024 | GRANT_AWARD | CG Oncology, Inc. | 93,600 | 0.00 USD | deriv |
| 29 Jan 2024 | PURCHASE | CG Oncology, Inc. | 2,000 | 19.00 USD | |
| 24 Jan 2024 | GRANT_AWARD | CG Oncology, Inc. | 492,920 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Immunome Inc. | 58,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Immunome Inc. | 70,000 | 0.00 USD | deriv |
| 28 May 2021 | GRANT_AWARD | Immunome Inc. | 16,609 | 0.00 USD | deriv |
| 19 Apr 2021 | GRANT_AWARD | Immunome Inc. | 125,000 | 0.00 USD | deriv |